1. The use of digitalis for the treatment of congestive heart failure: A tale of its decline and resurrection

   • Frank I. Marcus

   Editorial Comment Pages: 473 - 476

2. Calcium channel antagonists, part I: Fundamental properties: Mechanisms, classification, sites of action

   • Lionel H. Opie

   Calcium Antagonists: Review Series Pages: 477 - 477

3. Calcium channel antagonists part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials

   • Lionel H. Opie

   Calcium Antagonists: Review Series Pages: 478 - 478

4. Calcium channel antagonists part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications

   • Lionel H. Opie

   Calcium Antagonists: Review Series Pages: 479 - 479

5. Calcium channel antagonists part IV: Side effects and contraindications drug interactions and combinations

   • Lionel H. Opie

   Calcium Antagonists: Review Series Pages: 480 - 480

6. Calcium channel antagonists part V: Second-generation agents

   • Lionel H. Opie

   Calcium Antagonists: Review Series Pages: 481 - 481

7. Calcium channel antagonists: part VI: Clinical pharmacokinetics of first and second-generation agents

   • Lionel H. Opie

   Calcium Antagonists: Review Series Pages: 482 - 497

8. Cardiovascular effects of leukotrienes

   • J. Fauler
   • J. C. Frölich

   Reviews Pages: 499 - 505

9. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return

   • Kotaro Gotanda
   • Hitoshi Yokoyama
   • Norio Taira

   Potassium Channels Pages: 507 - 515

10. Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension

    • Per Omvik
    • Per Lund-Johansen

    Hypertension Pages: 517 - 523

11. Left ventricular mass changes with nicardipine therapy in essential hypertension

    • Philippe Gosse
    • Philippe Lacroix
    • Modeste Dallocchio

    Hypertension Pages: 525 - 528

12. Pharmacokinetic and pharmacodynamic comparison of conventional and controlled release formulations of motoprolol in healthy chinese subjects

    • Yuan-Teh Lee
    • Chiau-Suang Liau
    • Cueng-Chi Chen

    Hypertension Pages: 529 - 533

13. Effect of amlodipine on myocardial functional and metabolic recovery following coronary occlusion and reperfusion in dogs

    • Garrett J. Gross
    • Neil E. Farber
    • Galen M. Pieper

    Experimental Pharmacology Pages: 535 - 543

14. The hemodynamic properties of amlodipine in anesthetised and conscious dogs: Comparison with nitrendipine and influence of beta-adrenergic blockade

    • Michael G. Dodd
    • Donald G. Gardiner
    • Roger A. Burges

    Experimental Pharmacology Pages: 545 - 555

15. Hemodynamic effects of SIN-1 in acute left heart failure

    • T. M. Ibrahim
    • P. H. Unger
    • S. Degre

    Heart Failure Pages: 557 - 561